Brief: Scope Fluidics Says FDA Certification For UNI FAST Panel Planned For Second Half Of 2027
25/09/2026 13:18
BRIEF-Scope Fluidics Says FDA Certification For UNI FAST Panel Planned For Second Half Of 2027 Sept 25 (Reuters) - Scope Fluidics SA SCPP.WA:
FDA CERTIFICATION FOR UNI FAST PANEL PLANNED FOR SECOND HALF OF 2027
CHANGE OF DEADLINE IS DICTATED BY INTENTION TO EXPAND SCOPE OF CONDUCTED CLINICAL TRIALS IN ORDER TO SUBMIT FOR FDA CERTIFICATION AS MANY ANTIBIOTICS AS POSSIBLE
Source text: ID:nEM16h7sGa
Further company coverage: SCPP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics' EDOCERA Project Meets Second Goal Of Developing Prototype Of Device For Detecting Stroke Symptoms
Brief: Scope Fluidics Q2 Net Loss At 10.1 Million Zlotys
Brief: Scope Fluidics Unit Signs Deal With Poland's PARP For Up To 14.4 Mln Zlotys In Funding For HYBOLIC Project
Brief: Scope Fluidics Says FDA Certification For UNI FAST Panel Planned For Second Half Of 2027
Brief: Scope Fluidics Extends Deadline For First Goal In Hybolic Project